Details

---

• Active Ingredient: Ticagrelor 90 mg per tablet.

• Registration Number (MAL): MAL20112115ARZ.

• Manufacturer: AstraZeneca AB, Södertälje, Sweden.

• Registration Holder: AstraZeneca Sdn. Bhd., Petaling Jaya, Selangor, Malaysia.

Indications

• Prevention of thrombotic cardiovascular events (including cardiovascular death, myocardial infarction, and stroke) in adult patients with acute coronary syndromes (ACS), such as unstable angina, non-ST elevation myocardial infarction (NSTEMI), or ST elevation myocardial infarction (STEMI).

• Reduction of the risk of stroke in patients with acute ischemic stroke or high-risk transient ischemic attack (TIA).

Instructions for Use

• Dosage:

  • Initiate treatment with a 180 mg loading dose (two 90 mg tablets).

  • Continue with 90 mg twice daily, co-administered with a maintenance dose of acetylsalicylic acid (ASA) 75–150 mg daily.

  • Treatment duration is typically up to 12 months unless clinically indicated otherwise.

• Administration:

  • May be taken with or without food.

  • For patients with swallowing difficulties, the tablet can be crushed, mixed with water, and administered immediately.

• Missed Dose:

  • If a dose is missed, take it as soon as remembered unless it's almost time for the next dose. Do not double the dose to make up for a missed one.